Aptevo Therapeutics Inc.
APVO
$4.83
-$0.02-0.31%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
5/11/2026
-
The Cerbat Gem
5/6/2026
-
TipRanks Financial Blog
5/6/2026
-
ACCESS Newswire
4/10/2026
-
Zacks Investment Research
4/1/2026
-
Ticker Report
3/26/2026
-
ACCESS Newswire
3/19/2026
-
ACCESS Newswire
3/11/2026
-
TipRanks Financial Blog
3/10/2026
-
TipRanks Financial Blog
3/10/2026
-
RTT News - Momentum Stocks
3/10/2026
-
TipRanks Financial Blog
3/10/2026
-
The Fly
3/10/2026
-
ACCESS Newswire
2/18/2026
-
GeekWire
2/14/2026
-
Ticker Report
2/3/2026
-
Seeking Alpha - Healthcare
2/3/2026
-
The Fly
2/3/2026
-
The Fly
2/3/2026
-
ACCESS Newswire
1/28/2026
-
GuruFocus
1/28/2026
-
The Fly
1/20/2026
-
Ticker Report
1/9/2026
-
GuruFocus
1/9/2026
-
GuruFocus
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, March 26, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 11 and 15 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
206 838 0500
Address
2401 4th Avenue
Seattle, WA 98121
Seattle, WA 98121
Country
Year Founded
Business Description
Sector
Aptevo Therapeutics Inc., a clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the...
more